A clinical trial being designed at McMaster University in Ontario aims to determine if CBD can safely and effectively treat anxiety.
Supported by Tilray, the eight-week study will look at conditions such as General Anxiety Disorder and Panic Disorder.
Participants will receive up to 800 mg/day of Tilray’s CBD oil capsules.
The study will be led by a widely published psychiatry professor Michael Van Ameringen, MD, FRCPC.
Dr. Van Ameringen is specializes anxiety disorders in patients who also suffer from mood disorders (e.g. bipolar) and/or OCD.
He serves on the board of the Anxiety and Depression Association of America and is on the editorial board for the journal Depression and Anxiety.
The study is expected to take approximately two years to complete.